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RESEARCH ARTICLE
Altering lamina assembly reveals lamina-dependent and
-independent functions for A-type lamins
Monika Zwerger1, Heidi Roschitzki-Voser1, Reto Zbinden1, Celine Denais2, Harald Herrmann3, Jan Lammerding2,
Markus G. Grütter1 and Ohad Medalia1,4,*
ABSTRACT
Lamins are intermediate filament proteins that form a fibrous
meshwork, called the nuclear lamina, between the inner nuclear
membrane and peripheral heterochromatin of metazoan cells. The
assembly and incorporation of lamin A/C into the lamina, as well as
their various functions, are still not well understood. Here, we
employed designed ankyrin repeat proteins (DARPins) as new
experimental tools for lamin research. We screened for DARPins
that specifically bound to lamin A/C, and interfered with lamin
assembly in vitro and with incorporation of lamin A/C into the native
lamina in living cells. The selected DARPins inhibited lamin assembly
and delocalized A-type lamins to the nucleoplasm without modifying
lamin expression levels or the amino acid sequence. Using these
lamin binders, we demonstrate the importance of proper integration of
lamin A/C into the lamina for nuclear mechanical properties and
nuclear envelope integrity. Finally, our study provides evidence for
cell-type-specific differences in lamin functions.
KEY WORDS: DARPins, Assembly, Lamina, Lamins, Nuclear
envelope, Nucleus
INTRODUCTION
Lamins assemble into an intricate filamentous meshwork termed the
nuclear lamina, a protein layer underlying the inner nuclear
membrane (INM) (Dechat et al., 2010b, 2008; Shimi et al., 2008).
Four major lamin isoforms constitute the lamina in mammalian
cells. Two A-type lamins, lamin A and lamin C (herein referred to as
lamin A/C), are alternative splice variants of the LMNA gene,
whereas the B-type lamins lamin B1 and B2 are encoded by
independent genes, LMNB1 and LMNB2, respectively (Lin and
Worman, 1993; Peter et al., 1989; Vorburger et al., 1989). A-type
lamins are mainly expressed in differentiated cells, whereas all
nucleated cells express at least one B-type lamin throughout all
developmental stages (Worman et al., 1988).
One major function of lamins is to mechanically support the
nuclear envelope and to determine the mechanoelastic properties of
nuclei. However, lamin A/C was found to also participate, directly
or indirectly, in major nuclear processes, including chromatin
organization, transcriptional regulation, cell proliferation, DNA
replication and repair, as well as stem cell maintenance and
differentiation (reviewed in Dechat et al., 2010a). Despite extensive
research, the various functions of these proteins have remained
imprecisely defined (Burke and Stewart, 2013). Cell-type-specific
lamina composition, as well as differential expression of interaction
partners at the nuclear envelope, might account for the different
roles of lamins in specific tissues, and thus might explain conflicting
results and imprecise definitions of lamin functions.
Regardless of the progress in the development and improvement
of microscopy techniques, the assembly of lamins and the structural
organization of the lamina in somatic cells is still largely elusive
(Zwerger and Medalia, 2013). All lamins display a conserved
tripartite structure, comprising a central α-helical rod domain
flanked by a short head domain and a tail domain with a nuclear
localization signal, as well as an immunoglobulin (Ig)-fold (Dhe-
Paganon et al., 2002; Loewinger and McKeon, 1988; Shumaker
et al., 2005). Based on in vitro studies, it has been suggested that
lamins, like all intermediate filament (IF) proteins, form
approximately 50-nm long dimers arising from two parallel
monomers that interact through a central coiled-coil-forming
domain (Herrmann et al., 2007; Parry, 2005). Lamin dimers
interact longitudinally through head-to-tail association to form a
long polar polymer of dimers that can further assemble laterally into
high-molecular-mass structures (Aebi et al., 1986; Ben-Harush
et al., 2009; Goldberg et al., 2008; Herrmann and Aebi, 2004; Stick
and Goldberg, 2010). On the cellular level, light microscopy data
and biochemical fractionation experiments indicate that different
lamin isoforms assemble into separate but interconnected networks
(Kolb et al., 2011; Shimi et al., 2008). Notably, a small fraction of
lamins (approximately 10% of A-type lamins) also localizes within
the nuclear interior, where they interact with numerous nuclear
binding partners (Dorner et al., 2007; Kolb et al., 2011). Although
these nucleoplasmic lamins display higher mobility, their
oligomeric state is yet undefined (Shimi et al., 2008). The term
‘lamina’ thus defines assembled lamins at the nuclear envelope,
whereas the term ‘nucleoplasmic lamins’ refers to lamins within the
nuclear interior. It has so far remained unclear whether these two
lamin populations exert different functions in the nucleus.
In order to gain a deeper understanding of the mechanisms
underlying lamin functions and assembly, as well as the effects of
mutations, novel tools need to be devised and employed to
circumvent current limitations. In contrast to IF proteins, for which
no specific polymerization inhibitors have been characterized as of
yet, a multitude of such inhibitors exist for microtubules and actin
filaments, and their discovery has led to major breakthroughs in
these fields of research (Pollard, 2007; Svitkina and Borisy, 1999).
Such tools have enabled the study of actin dynamics, and the first
crystal structures were determined for globular actin in complexes
with deoxyribonuclease I, gelsolin or profilin, which all prevent its
polymerization (Otterbein et al., 2001). In analogy to the actin field,
inhibition of lamin polymerization in cells would allow for deeperReceived 19 March 2015; Accepted 13 August 2015
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insights into lamina assembly in vivo, and enable us to decipher the
roles of lamina incorporation for various lamin functions, without
introducing mutations or interfering with the expression levels of
lamins.
In this study, we decided to screen for lamin-specific binding
proteins using a library of designed ankyrin repeat proteins
(DARPins) (Binz et al., 2004). DARPins are small
(approximately 18 kDa) engineered proteins that can be selected
to bind precisely and with high affinity to certain subdomains of
lamin proteins, and can thus interfere with binding of lamins to
specific interaction partners or with lamin self-assembly. Here, we
describe the selection and characterization of high-affinity
DARPins that target lamin A/C and specifically inhibit lamin
oligomerization. These DARPins can be utilized as tools to either
interfere with lamin A oligomerization in vitro, or to inhibit the
incorporation of lamin A/C into the lamina in vivo. By expressing
DARPins in cultured cells, we demonstrate the importance of
incorporation of lamin A/C into the lamina for nuclear envelope
integrity, nuclear stiffness and morphology.
In summary, the DARPins employed in our study provide a
powerful tool to study aspects of lamin A/C and the nuclear lamina
that have been, so far, difficult to address.
RESULTS
There are currently only few molecular tools available to selectively
interfere with the assembly or functions of IF proteins. Therefore,
we made use of DARPin technology to generate specific and robust
binders of lamin A that can be used as tools for studying these
proteins, in particular their assembly and functions, in vitro as well
as in vivo.
Identification of selective DARPin binders of human lamin A
that interfere with lamin A assembly
The selection of DARPins that specifically bind to lamin A was
performed with standard ribosome display using an N3C library
(Seeger et al., 2013). As the target protein, we used recombinant
human lamin A that had been reconstituted in dimerization buffer
(Taimen et al., 2009). After four ribosome-display selection rounds,
DARPins were analyzed for target binding by crude cell extract
enzyme-linked immunosorbent assay (ELISA). We expressed and
purified the 19 most promising candidates and used surface plasmon
resonance to determine the properties of their binding to lamin A.
Sixteen candidates showed binding constants that were mostly in the
low nanomolar range (supplementary material Table S1) and were
therefore considered as high-affinity binders for human lamin A.
We next screened for DARPins that not only bound to the
protein but also interfered with lamin A polymerization. First, we
analyzed the effect of DARPins on lamin assembly in vitro.
Human lamin A that had been purified and reconstituted in
dimerization buffer was incubated with lamin-A-specific
DARPins, or a control DARPin that had been randomly chosen
from the library [E3_5 (Binz et al., 2006)] and does not bind to
lamin A (supplementary material Fig. S2A,B, Fig. S4A,B).
Lamin assembly was then initiated through stepwise dialysis into
buffers with reduced ionic strength and analyzed by
centrifugation. High-molecular-mass assemblies sediment into
the pellet, whereas lamins in low-oligomeric states remain in the
supernatant (Aebi et al., 1986). From the set of selectedDARPins,
four of them inhibited lamin assembly, retaining lamin A in the
supernatant after centrifugation (DARPins LaA_3, LaA_4,
LaA_5 and LaA_9), two had a mild impact on assembly
(LaA_6 and LaA_19) and 13 DARPins did not affect assembly
(Fig. 1; supplementary material Fig. S1A). The strongest
inhibition of lamin A assembly in vitro was detected with
DARPins LaA_3 and LaA_4.
Lamin A/C contain dozens of modification sites – e.g.
phosphorylation and acetylation sites – that can change their
biochemical properties in vivo. Therefore, we studied the effect of
DARPins on lamin A/C assembly in mammalian cells. We stably
expressed DARPins specific for lamin A in HeLa-K cells and
monitored the localization of laminA/C through immunofluorescence
(Fig. 1). Although someDARPins had no effect on the localization of
lamin A/C at the nuclear envelope, several DARPins caused a
substantial delocalization of lamin A/C to the nuclear interior. The
highest levels of delocalization, based on immunofluorescence
microscopy and fluorescence intensity measurements, were found in
cells that expressed DARPins LaA_1 and LaA_2 (supplementary
material Fig. S1B,C). Interestingly, these DARPins did not affect
lamin assembly in vitro, whereas the DARPins that prevented the
assembly of high-molecular-mass complexes in vitro – e.g. LaA_3
and LaA_4 – did not show substantial effects on lamin A/C
localization in vivo (Fig. 1).
To assess whether the influence of DARPins LaA_1 and LaA_2
on lamin A/C localization was a direct effect caused by the DARPin
interactions with A-type lamins, we tested whether these DARPins
bound to additional cellular proteins – other than lamin A/C –
in vivo. Therefore, we performed a co-immunoprecipitation assay
using HeLa-K cells that stably expressed mCherry-tagged DARPins,
and analyzed the DARPin-interacting proteins by western blot
analysis and mass spectrometry (supplementary material Fig. S2).
As expected, all four lamin-A/C-specific DARPins interacted with
twomajor proteins (supplementary material Fig. S2A) – lamin A and
lamin C (supplementary material Fig. S2B,C).
DARPin inhibitors do not alter A-type lamin protein levels, but
do affect lamin subnuclear localization and assembly state
To determine the cellular effects of A-type lamin redistribution
from the lamina to the nucleoplasm, we generated a panel of
modified U2OS cells (Fig. 2A). These cells expressed the lamin-
A-specific DARPins LaA_1 and LaA_2 (which caused a
redistribution of A-type lamins from the nuclear envelope in
Fig. 1. DARPins selected to bind to lamin A can alter lamin assembly
in vitro and in vivo. Left panels, lamin A in vitro assembly was performed in
the absence of DARPins (no DARPin, buffer), in the presence of a control
DARPin (E3_5) or in the presence of the indicated DARPins that specifically
bound to human lamin A. Samples were centrifuged for 35 min at 50,000 g,
and the supernatant (SN) and pellet (P) fractionswere analyzed by SDSPAGE
and staining with Coomassie Blue. Right panels, confocal images of HeLa-K
cells that stably expressed DARPins and were immunostained for lamin A/C
(red). DARPin-expressing cells were identified by the bicistronic expression of
EGFP (not shown). Scale bar: 10 µm.
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HeLa-K cells), or LaA_3 and LaA_4 (which did not affect the
localization of A-type lamins in HeLa-K cells). Notably, cells with
nucleoplasm enriched for A-type lamins were viable and
proliferated normally (data not shown).
As observed for HeLa-K cells, expression of DARPins LaA_1
and LaA_2 in U2OS cells resulted in a redistribution of lamin A/C
to the nucleoplasm, which was associated with a high fraction of
irregularly shaped nuclei. By contrast, lamin A/C localized
normally to the nuclear rim in cells that expressed the DARPins
LaA_3 and LaA_4 (Fig. 1, Fig. 2A). These observations confirm
that DARPins LaA_1 and LaA_2, but not LaA_3 and LaA_4, alter
lamina assembly in vivo.
Importantly, neither the localization of B-type lamins, of the
lamin-binding proteins Lap2α, Lap2β, LBR, nor of diverse markers
for euchromatin and heterochromatin were altered as a result of
delocalization of lamin A/C to the nucleoplasm through DARPins
LaA_1 and LaA_2 (Fig. 2A, data not shown). However, we
observed a redistribution of emerin from the nuclear envelope to the
cytoplasm in cells that expressed DARPins LaA_1 and LaA_2. The
same phenotype was observed in U2OS cells that had depleted
levels of A-type lamins as a result of RNA interference (RNAi)
(Fig. 2A). Moreover, the mislocalization of emerin was confirmed
in HeLa-K cells that stably expressed DARPins LaA_1 and LaA_2
(data not shown). Our observations thus indicate that anchorage of
emerin to the INM depends not only on the presence of lamin A/C
(Nagano et al., 1996; Sullivan et al., 1999) but also on its
incorporation into the nuclear lamina.
Next, we analyzed the polymerization state of the A-type lamins in
cells that expressed DARPins LaA_1 and LaA_2. Cells from the panel
of modified U2OS were incubated in mild extraction buffer containing
0.2% NP40, and then centrifuged, and supernatants containing the
extracted proteins, as well as the pellets, were analyzed by western
blotting (Fig. 2B). This differential extraction experiment confirmed
that a large fraction of A-type lamins – i.e. more than 40% of the total
lamin A or lamin C fraction –was found in the supernatant of cells that
expressed the DARPins LaA_1 or LaA_2, even after centrifugation at
50,000 g (Fig. 2B,C; supplementary material Fig. S3A). By contrast,
more than 90% of the lamin A and lamin C fraction was found in the
pellets from all other cell lines, including U2OS cells that expressed
LaA_3 and LaA_4. B-type lamins could not be extracted under these
conditions from any cell line (Fig. 2B). These results indicate that the
nucleoplasmic lamins, as a result of DARPins LaA_1 and LaA_2, are
not assembled into large filaments and are not tightly associated with
nuclear proteins or high-molecular-mass complexes.
Despite their altered assembly state and localization, the protein
levels of A-type lamins remained almost unchanged in cells that
expressed DARPins LaA_1, LaA_2, LaA_3 and LaA_4 (Fig. 2D;
supplementary material Fig. S3B,C). The protein levels of B-type
lamins and the lamin-binding proteins emerin, Lap2α and LBR
were also comparable in all cell lines. In summary, the presence of
DARPins LaA_1 and LaA_2 interferes with the incorporation of
A-type lamins into the lamina and causes a redistribution of emerin
to the endoplasmic reticulum (ER). Moreover, a large fraction of the
A-type-lamin–DARPin complexes in the nucleoplasm exist in a
non-polymerized state.
DARPin–lamin complexes remain in the nucleoplasm at the
end of mitosis and retain a high level of phosphorylation at
Ser22
We next assessed whether DARPins LaA_1 and LaA_2 have the
potential to cause delocalization of A-type lamins from an assembled
lamina network. Alternatively, they might bind to nucleoplasmic
A-type lamins during mitosis and prevent their integration into the
lamina during nuclear envelope reassembly. As a first step, we
investigated the effect of DARPin LaA_1 on interphase HeLa-K cells
that stably expressed green fluorescent protein (GFP)tagged lamin-A
(GFP–lamin-A). These cells were briefly permeabilized with
detergent to allow penetration, then incubated with mCherry-tagged
LaA_1. The DARPin mCherry–LaA_1 bound to the lamins at the
nuclear envelope but did not cause a delocalization of GFP–lamin-A
to the nucleoplasm over a period of 60 min, indicating that DARPin
binding did not affect crucial GFP–lamin-A interactions at the nuclear
envelope (Fig. 3A). Next, we transiently expressed mCherry–LaA_1
in these HeLa-K cells and monitored the reassembly of GFP–lamin-
A at the end of mitosis. In cells that displayed an increase in
mCherry–LaA_1 levels during mitosis, GFP–lamin-A failed to re-
integrate into the lamina (Fig. 3B, arrowheads), whereas GFP–
lamin-A reassembled normally into the lamina of untransfected
daughter cells (Fig. 3B, asterisks). Thus, we conclude that DARPin
LaA_1 binds to A-type lamins in the lamina but does not mediate
their delocalization into the nucleoplasm; rather, LaA_1 prevents
unassembled A-type lamins from re-associating with the lamina at
the end of mitosis.
Lamina reassembly is usually initiated by the activity of mitotic
phosphatases that remove the mitotic phosphate groups from A-type
lamins in late anaphase to early telophase (Thompson et al., 1997;
Wurzenberger and Gerlich, 2011). The Ser22 residue in lamin A/C
is one of four major amino acids that are hyperphosphorylated
during mitosis, but it is also a high-turnover site during interphase.
Moreover, the phosphorylation state of Ser22 influences subnuclear
localization of lamin A/C (Buxboim et al., 2014; Heald and
McKeon, 1990; Kochin et al., 2014). Interestingly, U2OS cells
that expressed LaA_1 and LaA_2 displayed a higher level of
phosphorylation at Ser22 compared to control cells, indicating that
the subnuclear localization of A-type lamins correlates with Ser22
phosphorylation status (Fig. 3C). We, however, cannot exclude the
possibility that high levels of phosphorylation at Ser22 are linked to
a certain degree of degradation in the case of cells expressing the
DARPins LaA_1 and LaA_2 (Fig. 3C,D) (Buxboim et al., 2014). In
summary, DARPin LaA_1 binds to both assembled A-type lamins
at the nuclear envelope as well as nucleoplasmic lamin A/C during
mitosis, and the latter prevents their incorporation into the lamina
after mitosis. These nucleoplasmic A-type lamins display increased
Ser22 phosphorylation.
Lamin A/C associated with the lamina is required for nuclear
envelope and chromatin organization in human dermal
fibroblasts
The experimental system we generated through modification of
U2OS cells allows us to differentiate between lamina-dependent
and lamina-independent lamin A/C functions. It has been
previously reported, however, that cancer cells such as HeLa-K or
U2OS are less sensitive to alterations of lamin levels than non-
cancer cells (Dorner et al., 2006; Pekovic et al., 2007). We,
therefore, extended our studies to investigate the effects of DARPins
on immortalized human dermal fibroblasts (HDFs). As control cells,
we used a fibroblast cell line isolated from an individual
homozygous for the LMNA Y259X mutation that completely
lacks A-type lamins. It was previously shown that a subset of these
HDF Y259X cells display abnormally shaped nuclei with altered
chromatin organization and gross nuclear envelope alterations,
including nuclear envelope areas in which B-type lamins, emerin,
nesprin-1, LAP2β and Nup153 were undetectable (Muchir et al.,
2004; van Engelen et al., 2005).
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Fig. 2. See next page for legend.
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Surprisingly, similar effects were observed in a subset of HDF
cells that expressed the DARPins LaA_1 and LaA_2 (Fig. 4A). As
expected, in HDFs that expressed these DARPins, A-type lamins
were distributed throughout the nucleoplasm. In these cells, we
often observed nuclei in which the nuclear envelope composition at
one or both poles appeared to be grossly altered (Fig. 4A, arrows). In
particular, lamin B1, Lap2β and nuclear pore complexes (NPCs)
were absent in these areas but localized normally in neighboring
nuclear envelope areas of the same nucleus. DNA labeling using
Hoechst 33342 stain displayed either weak chromatin staining or
granular staining, indicating altered chromatin structure at
dysmorphic nuclear poles. Emerin was found to be largely
mislocalized from the nuclear envelope to the cytoplasm.
Disturbed nuclear envelope composition at nuclear poles was
rarely detected in HDFs that expressed the DARPins LaA_3 and
LaA_4 (Fig. 4B). As reported for HDF Y259X cells, the fraction of
cells displaying these nuclear envelope disruptions decreased with
increasing passage number, indicating that these cells either divided
more slowly in comparison to cells with intact nuclei, or that the
integrity of the nuclear envelope was restored in some of these cells.
In our experiments, the decrease in the number of cells with a
disrupted nuclear envelope was accompanied by a decline in the
number of nuclei in which A-type lamins localized to the
nucleoplasm, despite selection pressure on DARPin expression
(Fig. 4B). However, among the cells with nucleoplasmic A-type
lamin localization, the fraction of disrupted nuclear envelopes
remained high (>50%, Fig. 4C).
These combined observations led us to conclude that cells in
which nuclear envelope localization of A-type lamins was restored
(e.g. cells with low DARPin expression) have a growth advantage
over those with mainly nucleoplasmic A-type lamins. Furthermore,
cells with nucleoplasmic A-type lamins were prone to nuclear
envelope damage, independent of the passage number (Fig. 4C). In
summary, HDF but not cancer cells displayed major nuclear
envelope alterations that were comparable to the knockout
phenotype, indicating that lamina-associated A-type lamins are
required for nuclear integrity in this cell type.
The contributions of A-type lamins to nuclear mechanical
properties are mostly lamina-dependent
Studies on wild-type and lamin-deficient mouse embryonic
fibroblasts (MEFs) have previously shown that lamin A is a major
determinant of nuclear stiffness and that loss of A-type lamins leads
to more deformable and more fragile nuclei (Buxboim et al., 2014;
Lammerding et al., 2006, 2004; Swift et al., 2013). It has so far
remained unclear, however, whether nuclear stiffness is determined
solely by lamina-associated lamins or whether nucleoplasmic
lamins also contribute, possibly by forming a nucleoplasmic
scaffold or by influencing chromatin organization.
Aswe had observed a high fraction ofmisshapen nuclei inHeLa-K
and U2OS cells in which A-type lamins was delocalized to the
nucleoplasm (Fig. 1, Fig. 2A), we next studied the effects of lamin A/
C nuclear localization on the mechanical properties of nuclei.
We quantified the alterations in the shape of the nuclei by computing
the nuclear contour ratio (4π×area/perimeter2), an established
measurement of nuclear shape (Lammerding et al., 2005). The
contour ratio approaches the value of 1with increasing roundness of a
nucleus, whereas the value decreases with increasing convoluted
nuclear morphology. HeLa-K cells and those expressing the control
DARPin E3_5 had very similar nuclear contour ratios (0.79 for both
cell lines). Cells that expressed LaA_1 and LaA_2, despite normal
levels of lamin A expression, displayed abnormal nuclear shapes
with nuclear contour ratio values comparable to those of knockout
cells (0.70, 0.68 and 0.68 for LaA_1, LaA_2 and LMNA knockdown,
respectively; Fig. 5A; supplementary material Fig. S3B). This
observation demonstrates that lamina-incorporation of lamin A/C is
required to maintain nuclear morphology. The shapes of nuclei in
cells that expressed DARPins LaA_3 and LaA_4 were comparable to
those in control cells.
Abnormal nuclear morphology is often caused by decreased
nuclear stiffness, as has been demonstrated previously in HDFs and
MEFs that express laminopathic mutations or that lack lamin A/C
(Zwerger et al., 2013). We therefore studied nuclear stiffness by
analyzing the nuclear deformability of wild-type HeLa-K andHeLa-
K cells that expressed the different DARPins. For this study, cells
were grown on transparent silicone membranes and imaged before
and during the application of strain to the elastic silicone membrane
(Fig. 5B). Nuclei of HeLa-K that expressed DARPins LaA_1 and
LaA_2, in which A-type lamins are mostly absent from the nuclear
envelope, deformed about 25% compared to the deformation of the
entire cell, whereas nuclei of control cells deformed, on average, by
10% compared to the deformation of the entire cell (Fig. 5B,C).
Thus, changes in A-type lamin localization and assembly alone are
sufficient to modulate nuclear stiffness, and the nuclear lamina
network apparently plays a major role in providing structural
support. However, HeLa-K cells with knockdown of LMNA
displayed even more deformable nuclei than cells expressing
DARPins LaA_1 and LaA_2, with an average value of more than
40% relative to the deformation of the entire cell. These results
suggest that the lamina-incorporated lamins contribute to nuclear
stiffness but that nucleoplasmic lamins play a role in nuclear
stiffening as well, presumably mediated by scaffolding
effects through interactions with multiple nuclear components or
by more indirect mechanisms, such as modulating global chromatin
structure.
DARPins selected for lamin A bind one of twomajor epitopes
To characterize the interactions of DARPins with human lamin A on
a molecular basis and to understand the different cellular effects
described above, we mapped the specific epitopes of DARPins
LaA_1 to LaA_4 on lamin A. Mature lamin A or various lamin A
fragments were immobilized on membranes and probed with these
DARPin candidates, which was followed by western blotting to
detect DARPins bound to the lamin variants (supplementary
Fig. 2. In vivo inhibitors do not alter A-type lamin protein levels but do
alter their subnuclear localization and assembly state. (A) Confocal
images of wild-type U2OS cells and cells that stably expressed a scrambled
small interfering (si)RNA (scrambled RNAi), an siRNA for LMNA silencing
(LMNA RNAi, LMNA in B, LMNA kd in C), the empty lentiviral plasmid (mock),
lamin A (lamin A OE), lamin C (lamin C OE), the control DARPin E3_5, or the
indicated different lamin A-specific DARPins (LaA_x, where x is the DARPin
identifier). Cells were immunostained with antibodies against lamin A/C, lamin
B1 and emerin. Scale bars: 20 µm. (B)Western blot analysis of the supernatant
(SN) and pellet fractions (P) of wild-type and modified U2OS cells shown in A
after extraction with a buffer containing 0.2% NP40 and using antibodies
against lamin A/C, lamin B1 and lamin B2. Note that the supernatant and pellet
were loaded in a 10:1 ratio. (C) Statistical analysis of the ratio of extracted to
total lamin A and lamin C in different U2OS cell lines. The average of three
individual experiments±s.e.m. is shown. Statistical significancewas calculated
using a one-way ANOVA test followed by Bonferroni’s multiple comparison
test, where *P≤0.05, **P≤0.01 and ***P≤0.001. (D) Western blot analysis of
lamin and lamin-binding protein levels in thewild-type andmodified U2OS cells
shown in A. The levels of exogenous lamin A, lamin C, and of DARPin
expression is reflected by levels of bicistronically expressed copGFP, a green
fluorescent protein cloned from Pontellina plumata. β-actin was used as
loading control.
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material Fig. S4A). These experiments revealed two main binding
epitopes that are recognized by the selected DARPins
(supplementary material Fig. S4A; summarized in Fig. 6).
DARPins LaA_1 and LaA_2 bound to amino acid residues 113–
140 of lamin A, a region within the coil-1B domain, whereas
DARPins LaA_3 and LaA_4 bound to a segment that includes the
head and coil 1A of the rod domain (amino acid residues 1–62).
Notably, the interactions of the DARPins LaA_3 and LaA_4 with
lamin A depend on the lysine residue at position 32 of lamin A
(supplementary material Fig. S4A; Fig. 6). Lamin A and lamin C are
alternative splice variants from the same gene that differ at their C-
termini, but are identical over the first 566 amino acids. DARPins
Fig. 3. A-type lamins delocalize to the
nucleoplasm post-mitotically and retain a high
level of phosphorylation. (A) HeLa-K cells that
stably expressed GFP–lamin-A were incubated with
mCherry-tagged DARPins E3_5 or LaA_1, and
Hoechst 33342 stain for up to 60 min, after brief
incubation with Triton X–100 to allow penetration of
the DARPins into the cells. Scale bar: 20 µm.
(B) Live-cell imaging of HeLa-K cells that stably
expressed GFP–laminA and had been transfected
with mCherry–DARPin LaA_1. GFP–lamin-A
reassociated with the lamina in non-transfected
daughter cells (marked with asterisks), whereas
expression of mCherry- LaA_1 blocked GFP–lamin-
A reassembly after mitosis (marked with
arrowheads). Scale bar: 20 µm. (C) Western blot
analysis of wild-type and modified U2OS cells to
detect A-type lamins, as well as A-type lamins
phosphorylated at amino acid Ser22. Nocodazole-
treated cells were used as a control for
phosphorylation, β-actin was used as loading
control. (D) Western blot analysis of wild-type and
modified U2OS cells treated with cycloheximide for
the indicated time points or DMSO to detect
degradation of A-type lamins. β-actin was used as
control for a stable protein, and the Coomassie-
stained membrane shows the efficiency of
cycloheximide treatment. In D, the upper band
represents lamin A and the lower band represents
lamin C.
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LaA_1, LaA_2, LaA_3 and LaA_4 therefore bind, as expected, to
both A-type lamin isoforms. We observed very weak binding of
DARPins LaA_1 and LaA_2, and moderate binding of DARPins
LaA_3 and LaA_4 to lamin B1 and lamin B2, and only weak
affinity, at most, to other members of the IF protein family
(supplementary material Fig. S4B,C). In summary, the DARPins
selected for our study bind with high affinity and specificity to
human lamin A/C at two distinct regions – the extended head
domain and coil 1B. Furthermore, the binding to these regions
specifically alters the localization and assembly properties of A-type
Fig. 4. HDFs with A-type lamin
delocalization display gross nuclear
envelope and chromatin alterations.
(A) Confocal images of wild-type HDFs, HDFs
homozygous for the mutation Y259X, which
completely lack A-type lamins, and HDFs that
stably expressed the empty lentiviral plasmid
(mock), the control DARPin E3_5, or the
indicated different lamin-A-specific DARPins.
Cells were immunostained with antibodies
against lamin A/C, lamin B1, emerin, Lap2β or
nuclear pore complexes (NPCs). Lentiviral
vectors contain an internal ribosome entry site
(IRES) site followed by the coding sequence
for copGFP for bicistronic expression.
Consequently, the green copGFP signal
directly correlates with DARPin expression
levels. Arrows indicate nuclear poles in which
the nuclear envelope composition appears to
be grossly altered. Scale bar: 20 µm.
(B) Statistical analysis of the percentage of
nuclei displaying disrupted nuclear envelope
organization at one (light grey for E3_5
control, green or turquoise for DARPins that
do or do not cause A-type lamin
delocalization, respectively, bottom of
columns) or both poles (dark grey, and green
or turquoise, top of columns), as determined
by staining for lamin B1, and at different
passages (P) after viral transduction. At least
300 cells were analyzed per data point.
(C) Statistical analysis of the percentage of
nuclei displaying disrupted nuclear envelope
organization (as determined after staining for
lamin B1) among cells in which A-type lamins
delocalized to the nuclear interior (as
determined by staining for lamin A/C) at
passages 1 and 10. NA, not applicable.
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lamins. The combined results of this study and the effects of
different DARPins are summarized in Fig. 7.
DISCUSSION
Despite the wealth of information on lamins and components of the
nuclear lamina, their diverse functions remain only incompletely
understood. Detailed insights into lamin assembly and functions are
fundamental for understanding the regulation of nuclear processes
and mechanical properties, but also essential for deciphering the
causes and effects of many diseases. During the past 25 years, more
than 400 mutations within the LMNA gene have been identified that
cause at least 12 distinct diseases, collectively termed laminopathies
(Worman, 2012). Laminopathies include muscular dystrophies, as
well as the premature aging disease Hutchison Gilford progeria
syndrome (Bertrand et al., 2011; Pereira et al., 2008; Worman,
2012). Currently, the lack of tools for altering the binding and
biochemical properties of lamins, and consequently the lamina,
present a limiting step in deciphering the precise functional and
structural aspects of these important cellular elements.
We describe here a set of DARPins that bind with high affinity and
specificity to either theN-terminal domain or to the central rod domain
of lamin A and lamin C. Expression of DARPins in living cells
prevents lamin A/C from polymerization and lamina incorporation,
which enables studying the role of lamina assembly for lamin A/C
functions (Fig. 7). DARPins thus represent an elegant approach to
alter assembly of these nuclear IF proteins in vitro as well as in vivo,
and to address important open questions in the lamin field.
Binding of DARPins to the head domain of lamin A inhibits
assembly in vitro
In vitro analysis of lamins suggests that lamin dimers interact
longitudinally to form head-to-tail polymers of dimers. This initial
process is dependent on the head domain of laminA (Isobe et al., 2007;
Spann et al., 1997), thus proteins that bind with high affinity to the
N-terminus of lamin A/C are expected to inhibit their assembly. Here,
we have identified DARPins that specifically bind to the head domain
and coil 1A (amino acids 1–62) of human lamin A, with Lys32 as an
amino acid that is crucial for their binding (Fig. 6; supplementary
material Fig. S4A). Notably, it is very possible that the actual binding
epitope for DARPins LaA_3 and LaA_4 comprises a shorter stretch
than amino acids 1–62 – e.g. only the head domain – but that these
DARPins bind only to dimerized lamin A. Consequently, additional
amino acids from the central rod might be required, not necessarily for
the interaction itself but for dimerization of the fragments.
DARPins LaA_3 and LaA_4 inhibit the formation of large lamin
A assemblies, as lamin A was recovered from the supernatant after
centrifugation (Fig. 1). The fact that DARPins that bind to the
N-terminus of human lamin A interfere with in vitro assembly is
consistent with the current model, according to which the head-to-
tail association of lamin dimers represents the fundamental step in
longitudinal self-assembly (Aebi et al., 1986; Herrmann and Aebi,
2004). Presumably, these DARPins inhibit the formation of head-
to-tail polymers and therefore keep lamins in a low oligomeric state.
Binding of DARPins to the central coiled-coil domain of lamin
A interferes with in vivo lamin A/C polymerization and lamina
incorporation
The assembly of lamin A/C and its incorporation into the nuclear
lamina is not yet understood. Several studies employ lamin A
variants that are mutated at distinct amino acids, and thereby have
identified sites that are crucial for lamina incorporation. Mutations
Fig. 5. Nuclear mechanical properties are impaired if A-type lamins are
not incorporated into the lamina. (A) Quantitative analysis of nuclear
roundness by assessing the nuclear contour ratio of wild-type HeLa-K cells
and cells that stably expressed GFP–lamin-A at low and high expression levels
(LaA OE 1 and LaA OE 2, respectively), a scrambled siRNA, an siRNA to
induce LMNA silencing (LMNA kd), the control DARPin E3_5, or the indicated
different lamin-A-specific DARPins. Values represent the average nuclear
contour ratio of >300 nuclei±s.e.m. (B) Changes in the nuclear shape of
unstretched (pre-strain, upper panel) and fully stretched (full strain, middle
panel) wild-type and the modified HeLa-K cells. Images in the lower panels
represent nuclei under strain, overlaid with the nuclear contour from the pre-
stretch state in red. Scale bar: 5 µm. (C) Statistical analysis of nuclear
deformation of wild-type and modified HeLa-K cells. Values represent the
average normalized nuclear strain (inferred from the ratio of induced nuclear
strain to the applied membrane strain) of ≥100 nuclei±s.e.m. Statistical
significance in A and C was calculated using a one-way ANOVA test followed
by Bonferroni’s multiple comparison test. A P-value of >0.05 was considered
as not significant (n.s.); ***P≤0.001.
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in the rod domain that alter amino acids L85, N195, E358, M371
and R386 cause impaired lamina assembly, indicating the
involvement of the entire rod domain in this process (Holt et al.,
2003; Raharjo et al., 2001; Zwerger et al., 2013). Recent studies
have found that phosphorylation of amino acid residue Ser22, and to
a lesser extent of other phosphosites along the protein, causes a shift
in the localization of lamin A from the nuclear envelope to the
nucleoplasm and increases mobility (Buxboim et al., 2014; Kochin
et al., 2014). However, the distinct steps of lamina incorporation are
still elusive, and it remains unclear whether lamin proteins attach to
the nuclear lamina as dimers or pre-assembled filaments. Moreover,
it is still open as to which components of the nuclear envelope are
required to interact with lamin A in order to achieve proper
incorporation of lamins into the nuclear lamina.
In this work we show that DARPins that bind to the N-terminal
domain of lamin A/C (LaA_3 and LaA_4) do not affect their
incorporation into the nuclear lamina, whereas DARPins that
interact with A-type lamins through coil 1B of the central rod
domain (LaA_1 and LaA_2) cause a substantial delocalization of A-
type lamins to the nucleoplasm. Because binding of DARPins
LaA_3 and LaA_4 to the lamin A/C head domain does not abolish
its nuclear envelope localization in vivo, a fully accessible head
domain is apparently not required for lamina incorporation.
These results may suggest that (i) the N-terminal domain is
required for in vitro head-to-tail assembly, whereas in vivo assembly
requires other domains of lamin A/C, or (ii) that incorporation of
A-type lamins into the lamina does not require large filamentous
lamin structures. Indeed, to our knowledge there is currently no
sufficient evidence that lamin A or lamin C form ‘classic’ filaments
in mammalian somatic cells. Only for B-type lamins have such
endogenous bona fide filaments been observed, albeit not in
mammalian somatic cells but in Xenopus laevis oocytes (Aebi et al.,
1986; Goldberg et al., 2008). A-type lamin dimers might also
polymerize in the form of patches or sheets that might cover a
filamentous B-type lamin system.
DARPins LaA_1 and LaA_2 bind to A-type lamins during
mitosis and prevent their oligomerization, as judged by
ultracentrifugation analyses, as well as their incorporation into the
lamina (Fig. 3B; supplementary material Fig. S3A; Fig. 1, Fig. 2A).
The nucleoplasmic localization of A-type lamins in these cells is
accompanied by high levels of phosphorylated Ser22. One potential
explanation might be that DARPin binding blocks substrate
recognition or the binding of phosphatases, thereby keeping
A-type lamins in a soluble ‘mitotic’ state, in which they are
unable to polymerize. However, the latter is less likely because the
DARPin-binding site on lamin A/C lies approximately 100 amino
acids away from the phosphorylation site. It is also possible that
DARPins prevent lamina incorporation by blocking distinct
interactions with nuclear envelope components, and thus high
levels of phosphorylated Ser22 is not a cause for but a consequence
of nucleoplasmic localization.
To address this question, we had expressed the extended
DARPin-binding epitope of lamin A/C, amino acid residues
99–147, in HeLa-K cells in order to immunoprecipitate
interaction partners of this exact A-type-lamin domain. Despite
repeated attempts, however, we did not isolate any cellular binding
protein that might interact with the same lamin A/C domain as
DARPins LaA_1 and LaA_2 (data not shown). Although we cannot
Fig. 6. DARPins selected against lamin A bind to one of two major epitopes. Identification of the binding epitope of four selected DARPins to human
lamin A. Top, the protein structure of the full-length mature lamin A. The numbers in brackets represent the number of amino acid residues that comprise the
indicated domain. Bottom, selected fragments of lamin A used for epitope mapping (supplementary material Fig. S4). The red arrowhead indicates the position of
the deleted amino acid Lys32. Right, +, +/− and− indicate strong, moderate and no detectable DARPin binding to lamin fragments, respectively. DARPins LaA_1
and LaA_2 interacted with amino acids 113–140, and DARPins LaA_3 and LaA_4 bound to amino acids 1–62 of human lamin A. The numbers in brackets
represent the number of amino acid residue that comprise the indicated domain.
3615
RESEARCH ARTICLE Journal of Cell Science (2015) 128, 3607-3620 doi:10.1242/jcs.171843
Jo
u
rn
al
o
f
Ce
ll
Sc
ie
n
ce
exclude the possibility that DARPin binding blocks certain
interactions at the nuclear envelope, a thorough investigation of
post-translational modifications and phosphatase binding to
DARPin LaA_1–lamin A/C complexes might eventually lead to
further insights into the in vivo assembly of A-type lamins.
Our combined results from in vitro and in vivo data indicate
that incorporation of lamins into the lamina in living cells differs
from the assembly of recombinant lamin A. In vitro assembly
might reflect the homotypic interactions of lamins in the absence
of binding partners (Herrmann and Aebi, 2004). In cells,
however, lamin-bound chaperones could shield specific domains
and thus prevent such interactions. In addition, soluble and
membrane-bound lamin-binding partners and additional
scaffolding networks might be crucial for ordered in vivo lamin
assembly.
A-type lamin delocalization to the nuclear interior causes
cell-type-dependent nuclear envelope defects and provides
a model for testing lamina-dependent and -independent
functions of lamin A/C
Expression of DARPins LaA_1 and LaA_2 in cells resulted in the
delocalization of lamin A/C from the nuclear lamina to the
nucleoplasm. DARPins that interfere with lamin incorporation
into the nuclear lamina provide a novel and important tool for
differentiating between lamina-dependent and lamina-independent
functions of A-type lamins in living human cells. We confirmed the
effects of specific DARPins on lamin A/C incorporation into the
nuclear lamina in three independent cell lines. Notably, for all cell
types, cells that expressed the DARPins LaA_1 and LaA_2 were
viable and proliferated. The two cancer cell lines HeLa-K and U2OS
cells did not show nuclear envelope alterations, except for a
mislocalization of emerin from the nuclear envelope to the
cytoplasm, presumably to the ER (Fig. 2A; data not shown). This
effect has been previously described in MEFs carrying specific
mutations in the LMNA gene, as well as in LMNA-knockout MEFs.
It has been proposed that emerin mislocalization in these cells
reflects the requirement of A-type lamins for emerin to be anchored
to the nuclear envelope (Nagano et al., 1996; Sullivan et al., 1999).
The data provided here further suggests that the anchorage of emerin
is a lamina-dependent function and that the pure presence of A-type
lamins is insufficient for emerin anchorage.
Notably, lamin A/C delocalization alters several nuclear envelope
components in HDFs that are unaffected in cancer cells (Fig. 4A).
The phenotype of HDFs that expressed DARPins LaA_1 and LaA_2
is very similar to that described for HDF Y259X cells, which
completely lack A-type lamins. Thus, the consequences of loss
of A-type lamins are mimicked by inhibiting the incorporation of
A-type lamins into the nuclear lamina. In our hands, knockdown of
LMNA in HDFs repeatedly resulted in cellular growth arrest (data not
shown), in agreement with previous reports that have demonstrated
that nucleoplasmic LAP2α–lamin-A complexes are required for
human fibroblasts to maintain a proliferative state (Pekovic et al.,
2007). Our results strengthen this observation, as HDFs that
expressed the DARPins LaA_1 and LaA_2, and thus had
nucleoplasmic lamin A/C, did not display a proliferation block.
Lamin A/C might therefore fulfil a lamina-independent function that
is required for proliferation in HDFs but not in cancer cells, further
demonstrating cell-type-specific differences in the functions of
A-type lamins.
The reasons for cell-type-dependent effects of DARPins that bind
to lamin A/C is not entirely clear. We speculate that the composition
of nuclear envelope proteins, as well as the presence or absence of
nucleoplasmic lamin-binding partners might influence the stability
of the nuclear envelope (Korfali et al., 2012). These factors might as
well determine the precise functions of lamin A/C in a given cell
type. In addition, cancer cells frequently acquire mechanisms to
Fig. 7. Two sets of DARPins have different effects on lamin A in vitro and on A-type lamins at the cellular level.Summary of the impact of DARPins LaA_1,
LaA_2, LaA_3 and LaA_4 on A-type lamins. Top, protein structure of the full-length mature lamin A. The numbers in brackets represent the number of amino
acid residues that comprise the indicated domain. The framed lamin A head and coil-1 domain is again depicted enlarged, showing the DARPins binding to
the two main epitopes. Bottom, the effects of the two groups of DARPins are summarized. +, indicates effect was observed; −, indicates no effect was observed;
aa, amino acid residues; NLS, nuclear localization signal.
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override or reduce the activity of cell cycle checkpoints, which
might account for the observation that a proliferation block upon
lamin A/C loss occurs only in HDFs, whereas HeLa-K and U2OS
cells proliferate normally in the absence of A-type lamins (Helt and
Galloway, 2003; Lu et al., 2005; Pekovic et al., 2007). Our study
thus emphasizes that observations made in one cell line must be
interpreted with caution and cannot be generalized for all cell types.
One major function of lamins is to regulate the mechanical
properties of nuclei (Lammerding et al., 2006; Swift et al., 2013). The
findings presented here suggest that nuclear shape is dependent on
the incorporation of A-type lamins into the lamina, as the nuclear
contour ratios of cells that expressed LaA_1 and LaA_2 were
comparable to those of cells that lacked A-type lamins (Fig. 5A).
Nuclear deformability was increased in cells with nucleoplasmic A-
type lamins compared to control cells, but not to the same extent as in
cells that lacked A-type lamins. Nucleoplasmic lamin A/C might
therefore contribute to nuclear stiffness aswell, although these lamins
are not assembled into large polymers. NucleoplasmicA-type lamins
formmultiple interactionswith chromatin and nucleoplasmic factors,
such as Lap2α, pRB or PCNA, and might thereby support nuclear
stiffness and viscosity (Olins et al., 2009; Simon andWilson, 2013).
Although we cannot exclude the possibility that a minor fraction of
lamin A/C is still attached to the nuclear lamina in these cells, it is
likely that such amounts would not influence these measurements
significantly. Taken together, the mechanical properties of the
nucleus mostly rely on the incorporation of A-type lamins into the
lamina, although nucleoplasmic lamins presumably play a role in
nuclear resistance and strength as well.
In summary, we present here a new approach to alter lamin A/C
assembly and localization, based on DARPin technology. Different
DARPins inhibit the assembly of A-type lamins into higher order
structures either in vitro or in vivo and, thus, contribute to a more
differentiated description of lamin functions. Moreover, the use of
specific lamin-binding proteins enables the study of the effect of
distinct domains on protein interactions at the nuclear envelope,
without altering the lamin expression level. This innovative
approach can further be adopted for biochemical, biophysical and
cell biology studies of other IF proteins, and might shed light on
their cellular assemblies and functions.
MATERIALS AND METHODS
Plasmids
For DARPin selection, human mature lamin A (LMNA, UniProt accession
number P02545), was cloned with an N-terminal 6×His–TEV site and a C-
terminal AVI-tag in pET24d(+) (Novagen) to generate 6His-TEVlaminAAvi.
For protein expression, the coding sequences of DARPins were cloned
into pQE-30 (Qiagen) modified with an additional Myc-tag
(6HisDARPinsMyc), or into the standard vector pQE-30 (6HisDARPins).
For eukaryotic expression, coding sequences of selected DARPins were
cloned into pIRES-GFP or mCherry-C1 (mCherryDARPins, both Clontech).
Selected mCherryDARPins were amplified from the mCherry-C1 plasmid
and ligated into the pET24d(+) with N-terminal 6×His–TEV site
(6His-TEV-mCherryDARPins).
For lentiviral transduction, a pCDH-CMV-MCS-EF1-puro (SBI) was
modified to pCDH-CMV-MCS-IRES-copGFP-EF1-puro, and human lamin
A, lamin C and 6×His-tagged DARPins (6HisDARPins) were cloned into this
vector.
For epitope characterization, human lamin A, lamin A ΔK32 and lamin A
domain-truncated variants were ligated into pET24a(+) plasmid (Novagen)
without a tag, with N-terminal 6×His-TEV (6His-TEVLaA fragments), or, for
short lamin A fragments, with N-terminal 6×His–TEV site (6His-TEV-GFPLaA
fragments). Full-length clones of lamin B1 and lamin B2 (Schumacher et al.,
2006), keratins, desmin or vimentin were subcloned into pET24a(+). All
vector modifications were verified by Sanger sequencing.
Ribosome display, crude extract ELISA and surface plasmon
resonance analysis
For selection of lamin-A-specific DARPins, an N3C library was used, and
four standard ribosome-display selection rounds (Seeger et al., 2013) were
performed against immobilized 6His-TEVlaminAAvi, reconstituted in a
‘dimerization buffer’ containing 300 mM NaCl, 25 mM Tris (pH 8.0),
2 mM EDTA and 1 mM DTT (Herrmann and Aebi, 2004; Taimen et al.,
2009). Crude extract ELISA against reconstituted 6His-TEVlaminAAvi and
surface plasmon resonance analysis on a Proteon XPR36TM (Bio-Rad
Laboratories, Inc.) was performed as described previously (Seeger et al.,
2013).
Cell culture and cell treatment
HeLa-K cells, human osteosarcoma cells (U2OS; American Type Culture
Collection number HTB-96), HEK-293T cells, wild-type HDFs (Muchir
et al., 2004) and human fibroblasts carrying a homozygous nonsense
Y259X mutation in lamin A/C (van Engelen et al., 2005) were maintained
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml
streptomycin.
For induction of lamin A/C hyperphosphorylation, cells were arrested in
G2/M phase by treatment with 100 ng/ml nocodazole for 20 h, and mitotic
cells were collected by mitotic shake-off. To inhibit protein synthesis,
translation was blocked by treating cells with 100 μg/ml cycloheximide for
6, 12 or 24 h.
Cell line modifications
All modified HeLa-K cells presented – except for HeLa-K cells with stable
knockdown – were modified through transfection with Fugene HD
transfection reagent (Promega). At 24 h after transfection, positive cells
were selected by addition of Geneticin (Life Technologies) at a
concentration of 1.5 mg/ml to the culture medium for 2–3 weeks. To
increase the fraction of positive cells, cells were sorted for the bicistronically
expressed GFP or for the mCherry-tag by using fluorescence activated cell
sorting (FACS) at the ZMB Center for Microscopy and Image Analysis
(University of Zurich). U2OS cells, HDFs and HeLa-K cells were modified
through lentiviral infection [in the case of HeLa-K, cells were modified for
stable knockdown of lamin A/C (Sigma mission, clone number
NM_170707.1-752s1c1) and for the respective scrambled control] using
HEK-293T cells as packaging cells and the packaging vectors dMD2.G and
psPAX2 (Addgene), and following the Purefection protocol for Lentiviral
packaging (System Biosciences). 4 µg/ml puromycin (Invitrogen) was
added to the medium for selection of positive cells, and cell lines were
subsequently maintained in this selection medium.
Immunofluorescence and western blot analysis
Immunofluorescence and western blot analysis, including sample
preparation, were performed as previously described (Zwerger et al.,
2010). The following antibodies were used in this study: mouse anti-lamin
A/C (LaZ, Geiger et al., 2008), mouse anti-lamin A/C (clone 636, Santa
Cruz), goat anti-lamin B1 (clone M-20, Santa Cruz), mouse anti-lamin B2
(clone X223; Progen), guinea pig serum against LBR (LBR N-term, Cohen
et al., 2008), guinea pig serum against emerin (Em-N-term, Dreger et al.,
2002), guinea pig serum against Lap2α, mouse anti-Lap2β (mAb 16, Dechat
et al., 1998), rabbit anti-phosphorylated-Ser22 lamin A/C, mouse anti-β-
actin (catalog number A5441, Sigma-Aldrich), and mouse antibody against
red fluorescent protein (RFP; 3F5, Chromotek). FITC-, Cy3-, Cy5-,
Alexa488-, Alexa647- or peroxidase-conjugated secondary antibodies were
purchased from Jackson ImmunoResearch Laboratory. Primary and
secondary antibody dilutions were as recommended by the supplier.
Protein expression and purification
Biotinylated 6His-TEVlaminAAvi was generated through co-expression with
a plasmid containing the coding sequence for BirA in BL21-CodonPlus
(DE3) grown in terrific broth (Difco™ Terrific Broth) after induction with
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) for approximately
3 h at 37°C in the presence of biotin (Sigma-Aldrich); protein was then
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purified under denaturing conditions following the protocol of the
QiaExpressionist (Qiagen).
6HisDARPins (∼18 kDa) and 6His-TEV-mCherryDARPins (∼45 kDa) were
expressed in BL21-CodonPlus(DE3) grown in terrific broth after induction
with 1 mM IPTG for approximately 5 h at 37°C and 16 h at 18°C,
respectively, and purified as previously described (Seeger et al., 2013).
The plasmids encoding the human lamin A fragments comprising amino
acids 1–118, 1–263, 24–263, 190–316 and 264–402 in a pPEP-TEV vector
[ppep-6His-TEVLaA fragments, kind gift of Larisa Kapinos, Biozentrum,
University of Basel, Switzerland (Kapinos et al., 2010)], as well as those
encoding the 6His-TEVLaA fragments and 6His-TEV-GFPLaA fragments were
transformed into E. coli BL21-CodonPlus(DE3). Bacteria were cultured in
terrific broth, and protein expression was induced with 1 mM IPTG for 4–
6 h at 37°C. The untagged recombinant human proteins mature lamin A,
lamin A 1–646 Δ32, domain-deleted lamin A variants, lamin C, lamin B1
and lamin B2 were expressed and purified from BL21-CodonPlus(DE3) as
described (Taimen et al., 2009). Keratins, vimentin, desmin and
neurofilament L in a pET24a(+) vector were expressed and purified as
previously described (Herrmann et al., 2004, 2002).
Epitope characterization
For epitope characterization, protein samples of human lamin A or lamin A
fragments were loaded onto NuPAGE® Novex® 4–12% Bis-Tris gels
(LifeTechnologies) and either Coomassie-stained or blotted onto
Immobilon PVFD membranes (Millipore). Membranes were blocked in
PBST (PBS with 0.05% Tween-20) with 5% non-fat dried milk and
incubated with purified 6His-TEV-mCherry or 6His-TEV-mCherryDARPins at a
concentration of 100 µg/ml for 2 h. Bound proteins were detected with an
anti-RFP antibody. For testing DARPin binding to IF proteins, purified,
untagged human lamin A, lamin C, lamin B1 and lamin B2, keratin 5,
keratin 8, keratin 14, keratin 18, vimentin, desmin and neurofilament L were
loaded onto 4–12% Bis-Tris Gels. Analysis of DARPin binding was
performed as described above.
In vitro assembly
In vitro assembly of human lamin A was performed as previously
described with a few modifications (Zwerger et al., 2013). In brief, human
lamin A in dimerization buffer at a concentration of 0.2 mg/ml was
incubated with an excess of 6HisDARPins that were dialyzed into the same
buffer (at least 4× molar concentration) at room temperature for
1 h. Paracrystal assembly was initiated by a stepwise reduction of the
salt concentration from 300 to 50 mM NaCl. Samples were centrifuged for
35 min at 50,000 g and 4°C. Proteins in the supernatants were precipitated
using Trichloroacetic acid (TCA), and pelleted supernatant, as well as
pellets, were resuspended in Laemmli sample buffer and boiled for 5 min
at 95°C. The entire samples were separated on 12.5% SDS gels and
Coomassie-stained. For specific 6HisDARPins, the assay was performed in
three individual experiments.
Co-immunoprecipitation assay and mass spectrometry analysis
Cells were lysed for 20 min on icewith RIPA buffer [150 mMNaCl, 50 mM
Tris-HCl (pH 8.0), 1% NP-40, 0.1% sodium dodecyl sulfate, 0.5% sodium
deoxycholate, 0.5 mM EDTA] supplemented with cOmplete protease
inhibitor (Roche), 10 mg/ml Pefabloc and 4 mg/ml DNAse I. Lysates were
cleared by centrifuging, and supernatants were diluted in a 1:5 ratio with
‘Immunoprecipitation wash buffer’ containing 150 mMNaCl, 50 mM Tris-
HCl (pH 8.0), 0.5 mMEDTA and protease inhibitor, to a final concentration
of 0.2% NP-40, 0.02% sodium dodecyl sulfate and 0.1% sodium
deoxycholate. Diluted lysates were incubated with equilibrated RFP-
Trap_A beads (Chromotek) for 2 h at 4°C, then washed with 1:5 diluted
RIPA buffer, followed by several washing steps with immunoprecipitation
wash buffer. Bound proteins were eluted through addition of pre-heated
Laemmli sample buffer to the beads and incubation for 5 min at 95°C. For
western blot analysis, lysates of approximately 6.2×105 cells and
precipitates of approximately 2×104 cells were loaded onto 10% SDS
gels, representing an approximate 30:1 ratio of lysates (input) to
immunoprecipitates. For mass spectrometry analysis, precipitates of
approximately 2×107 cells were loaded onto a 4–12% Bis-Tris gel. The
gel was Coomassie-stained and the three major protein bands that co-
immunoprecipitated with mCherryDARPins were excised. Mass spectrometry
analysis was performed at the Functional Genomics Center Zurich.
Differential protein extraction
Approximately 3×106 cells were resuspended in 200 µl of lysis buffer
containing 0.5× PBS, 50 mM MOPS (pH 7.0), 10 mM MgCl2, 1 mM
EGTA, 0.2%NP40, cOmplete protease inhibitor and 0.75% saturated PMSF
in ethanol. Extraction with 0.2–1% NP40 detergent has been previously
shown to release only a small lamin A/C fraction but not lamina-associated
A-type lamins (Kolb et al., 2011). Extraction was performed at 4°C for
5 min. Insoluble cellular components were briefly spun down, and the
supernatant was boiled with Laemmli sample buffer. Alternatively, a part of
the supernatant was additionally centrifuged at 50,000 g for 35 min at 4°C,
then the supernatant was boiled with Laemmli sample buffer. The insoluble
fraction was boiled for 5 min at 95°C with urea sample buffer (10 M urea in
1.5× Laemmli sample buffer), and a 1:10 dilution of the pellet sample was
prepared. Supernatant and 1:10-diluted pellet fractions were separated on a
4–12%Bis-Tris gels. Differential extractions were performed independently
three times and quantified using ImageJ.
Nuclear shape analysis and nuclear strain analysis
For a quantitative assessment of the nuclear shape, the nuclear cross-
sectional area and perimeter of Hoechst-33342-stained nuclei was measured
using a custom-written MATLAB program (Lombardi et al., 2011). The
program automatically calculates the nuclear contour ratio (4π×area/
perimeter2), yielding a quantitative measure of nuclear roundness
(Lammerding et al., 2005). More than 300 nuclei from cells with
substantial green fluorescence (the bicistronically expressed GFP is a
marker for expression levels of DARPins) were analyzed per cell line.
To analyze the nuclear stiffness, we measured nuclear deformations in
response to substrate strain application and calculated the normalized nuclear
strain as described previously (Lombardi et al., 2011). Per cell line, ≥100
nuclei from cells with substantial green fluorescence were analyzed.
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